Home Newsletters Cell Therapy News Development of Allogeneic HSC-Engineered iNKT Cells for Off-the-Shelf Cancer Immunotherapy

Development of Allogeneic HSC-Engineered iNKT Cells for Off-the-Shelf Cancer Immunotherapy

0
By combining hematopoietic stem cell (HSC) gene engineering and in vitro differentiation, scientists generated human allogeneic HSC-engineered invariant natural killer T cells at high yield and purity.
[Cell Reports Medicine]

Sorry, but the selected Zotpress account can't be found.

Full ArticleGraphical Abstract
Exit mobile version